Neuroleptic malignant syndrome while on tiapride treatment.
Duarte
J
J
Campos
J M
JM
Cabezas
C
C
Sagredo
V
V
Cortina
J
J
Clavería
L E
LE
D018726:Anti-Dyskinesia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D013976:Tiapamil Hydrochloride / Q000009:adverse effects* / Q000627:therapeutic use
D018726:Anti-Dyskinesia Agents; D014150:Antipsychotic Agents; D013976:Tiapamil Hydrochloride